Mylabris

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1946-2017
02419462016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Small-molecule cell-permeable Bcl-2/Bcl-xL antagonist ABT-737 has recently emerged as a novel cancer therapeutic agent because it… (More)
Is this relevant?
2011
2011
The anticancer activity of the extract of blister beetle, Mylabris cichorii has been documented earlier by us. In the present… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
OBJECTIVE To compare the change of the content of cantharidin in Mylabris before and after biotransformation. METHODS The… (More)
Is this relevant?
2010
2010
BACKGROUND Norcantharidin, the demethylated analog of cantharidin derived from a traditional Chinese medicine, Mylabris, has been… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Norcantharidin (NCTD) is a small-molecule metastasis inhibitor without renal toxicity derived from a renal toxic compound… (More)
Is this relevant?
2006
2006
Mylabris is used in clinical therapy, but is always accompanied by cystitis. The toxic effects of mylabris on bladder are… (More)
  • figure 2
  • figure 4
  • figure 6
  • figure 8
  • figure 9
Is this relevant?
2005
2005
Cancer chemotherapy is often limited by patient's toxicity and tumor drug resistance indicating that new drug development and… (More)
Is this relevant?
2003
2003
Mylabris phalerata (MP) is an insect that has been used for the treatment of cancer in oriental medicine. In the present study… (More)
Is this relevant?
2000
2000
The cytotoxicity of crude insect drugs was measured using HeLa cells originating from human cervix and uterine cancer, using the… (More)
Is this relevant?
1990
1990
A fatal case of attempting to procure abortion by the ingestion of the crude extract of cantharides from over 200 dried Mylabris… (More)
Is this relevant?